logo
RTX (NYSE:RTX) Surprises With Strong Q2, Full-Year Outlook Slightly Exceeds Expectations

RTX (NYSE:RTX) Surprises With Strong Q2, Full-Year Outlook Slightly Exceeds Expectations

Yahoo22-07-2025
Aerospace and defense company Raytheon (NYSE:RTX) reported Q2 CY2025 results beating Wall Street's revenue expectations , with sales up 9% year on year to $21.58 billion. The company's full-year revenue guidance of $85.13 billion at the midpoint came in 1% above analysts' estimates. Its non-GAAP profit of $1.56 per share was 9.1% above analysts' consensus estimates.
Is now the time to buy RTX? Find out in our full research report.
RTX (RTX) Q2 CY2025 Highlights:
Revenue: $21.58 billion vs analyst estimates of $20.65 billion (9% year-on-year growth, 4.5% beat)
Adjusted EPS: $1.56 vs analyst estimates of $1.43 (9.1% beat)
Adjusted EBITDA: $3.34 billion vs analyst estimates of $3.25 billion (15.5% margin, 2.5% beat)
The company lifted its revenue guidance for the full year to $85.13 billion at the midpoint from $83.5 billion, a 1.9% increase
Management lowered its full-year Adjusted EPS guidance to $5.88 at the midpoint, a 3.3% decrease due to the company's "current assessment of the impact of tariffs"
Operating Margin: 9.9%, up from 2.7% in the same quarter last year
Free Cash Flow was -$72 million, down from $2.2 billion in the same quarter last year
Organic Revenue rose 9% year on year, in line with the same quarter last year
Market Capitalization: $202.5 billion
Company Overview
Originally focused on refrigeration technology, Raytheon (NSYE:RTX) provides a a variety of products and services to the aerospace and defense industries.
Revenue Growth
A company's long-term sales performance can indicate its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Unfortunately, RTX's 5.7% annualized revenue growth over the last five years was tepid. This fell short of our benchmark for the industrials sector and is a tough starting point for our analysis.
We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. RTX's annualized revenue growth of 8.8% over the last two years is above its five-year trend, suggesting some bright spots.
We can dig further into the company's sales dynamics by analyzing its organic revenue, which strips out one-time events like acquisitions and currency fluctuations that don't accurately reflect its fundamentals. Over the last two years, RTX's organic revenue averaged 10.6% year-on-year growth. Because this number is better than its normal revenue growth, we can see that some mixture of divestitures and foreign exchange rates dampened its headline results.
This quarter, RTX reported year-on-year revenue growth of 9%, and its $21.58 billion of revenue exceeded Wall Street's estimates by 4.4%.
Looking ahead, sell-side analysts expect revenue to grow 3.4% over the next 12 months, a deceleration versus the last two years. This projection doesn't excite us and indicates its products and services will face some demand challenges.
Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories.
Operating Margin
RTX was profitable over the last five years but held back by its large cost base. Its average operating margin of 7% was weak for an industrials business.
On the plus side, RTX's operating margin rose by 5.4 percentage points over the last five years, as its sales growth gave it operating leverage.
In Q2, RTX generated an operating margin profit margin of 9.9%, up 7.3 percentage points year on year. This increase was a welcome development and shows it was more efficient.
Earnings Per Share
We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company's growth is profitable.
RTX's unimpressive 4.8% annual EPS growth over the last five years aligns with its revenue performance. On the bright side, this tells us its incremental sales were profitable.
Like with revenue, we analyze EPS over a shorter period to see if we are missing a change in the business.
For RTX, its two-year annual EPS growth of 10% was higher than its five-year trend. This acceleration made it one of the faster-growing industrials companies in recent history.
In Q2, RTX reported EPS at $1.56, up from $1.41 in the same quarter last year. This print beat analysts' estimates by 9.1%. Over the next 12 months, Wall Street expects RTX's full-year EPS of $6.02 to grow 2.6%.
Key Takeaways from RTX's Q2 Results
We liked how RTX beat analysts' organic revenue expectations this quarter. On the other hand, its full-year EPS guidance was lowered and missed expectations due to the company's "current assessment of the impact of tariffs". This weighed on shares, and the stock traded down 2.1% to $148.50 immediately following the results.
Is RTX an attractive investment opportunity at the current price? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

Yahoo

time15 minutes ago

  • Yahoo

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the second quarter of 2025 on Wednesday, August 6, 2025, after market close. At 4:30 p.m. ET that day (1:30 p.m. PT), members of Revolution Medicines' senior management team will host a webcast to discuss the financial results for the quarter and provide an update on corporate progress. To listen to the live webcast, or access the archived webcast, please visit: Following the live webcast, a replay will be available on the company's website for at least 14 days. About Revolution Medicines, Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are currently in clinical development. The company anticipates that RMC-5127, a RAS(ON) G12V-selective inhibitor, will be its next RAS(ON) inhibitor to enter clinical development. Additional development opportunities in the company's pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit and follow us on LinkedIn. Revolution Medicines Media & Investor Contact:media@

Board Declares Quarterly Dividend and Elects New Officer
Board Declares Quarterly Dividend and Elects New Officer

Yahoo

time15 minutes ago

  • Yahoo

Board Declares Quarterly Dividend and Elects New Officer

WESTMINSTER, Colo., July 30, 2025 /PRNewswire/ -- Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable September 16, 2025, to shareholders of record as of September 2, 2025. The Board also elected Edmund "Ted" Doering to serve as Chief Information Officer (CIO) of the corporation. Ted recently joined Ball to succeed Brian Gabbard, who is planning to retire from the company at the end of September. Ted brings more than three decades of global IT leadership experience, most recently serving as executive vice president and CIO at Berry Global. Before joining Berry, Ted was Chief Digital Officer at Emerson Electric and CIO of Emerson Automation Solutions. Ted has deep expertise in driving value creation, delivery execution and enterprise risk management. Conference Call Details Ball will announce its second quarter 2025 earnings on Tuesday, August 5, 2025 before trading begins on the New York Stock Exchange. At 9 a.m. Mountain Time on that day (11 a.m. Eastern Time), Ball will hold its regular quarterly conference call on the company's results and performance. Please use the following URL to join via webcast: To participate in the live call Q&A session, North American callers should use the following number, 877-497-9071. International callers should use the following number, +1 201-689-8727. For those unable to listen to the live call, a taped replay and transcript of the event will be available within 48 hours on Ball's website at under "Financial Results." About Ball Corporation Ball Corporation supplies innovative, sustainable aluminum packaging solutions for beverage, personal care and household products customers. Ball Corporation employs 16,000 people worldwide and reported 2024 net sales of $11.80 billion, which excludes the divested aerospace business. For more information, visit or connect with us on LinkedIn or Instagram. View original content to download multimedia: SOURCE Ball Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Everest Group: Q2 Earnings Snapshot
Everest Group: Q2 Earnings Snapshot

Yahoo

time15 minutes ago

  • Yahoo

Everest Group: Q2 Earnings Snapshot

HAMILTON, Bermuda (AP) — HAMILTON, Bermuda (AP) — Everest Group, Ltd. (EG) on Wednesday reported second-quarter net income of $680 million. The Hamilton, Bermuda-based company said it had net income of $16.10 per share. Earnings, adjusted for non-recurring costs, were $17.36 per share. The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $15.14 per share. The reinsurance company posted revenue of $4.49 billion in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $4.4 billion. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on EG at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store